CERo Therapeutics News

Express News | CERo Therapeutics Presents Preclinical Data For AML On CER-1236 At Stanford Drug Discovery Symposium Highlighting Tumor Elimination And Manufacturing Attributes

BenzingaApr 30 09:14 ET

CERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing Attributes

SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) ("CERo") an innovative immunotherapy company seeking to advance the next generation of engineered T cell

GlobeNewswireApr 30 09:00 ET

CERo Therapeutics Files to Sell 26.62M Shares of Common Stock

Seeking AlphaApr 10 16:23 ET

NVCR, SBNY and VITL Are Among After Hour Movers

Seeking AlphaApr 1 17:08 ET

Trending Stocks Today: Avalo Therapeutics Surges 381.05%

March 28th - US stocks trending in regular trading hours.Gainers: $Avalo Therapeutics(AVTX.US)$ soars 381.05% to $22.85 with a turnover of $506.08 million. $Xilio Therapeutics(XLO.US)$ surges 130.04%

moomoo NewsMar 28 14:05 ET

KOD, ALLG and SST Among Mid-day Movers

Seeking AlphaMar 28 13:01 ET

AVLX, SGH and ETNB Are Among Pre Market Losers

Seeking AlphaMar 15 16:48 ET

RNLX, ASLN and SONN Among Pre-market Losers

Seeking AlphaMar 12 08:28 ET

ELTK, PSTX and LTRN Among Mid-day Movers

Seeking AlphaMar 11 12:49 ET

Lexicon Pharmaceuticals, Mesoblast, Ventyx Biosciences Among Healthcare Movers

Seeking AlphaMar 11 10:00 ET

SOS, MFG and LYT Among Pre-market Losers

Seeking AlphaMar 11 08:26 ET

Aptevo Therapeutics, Immuron, CASI Pharmaceuticals Among Healthcare Movers

Seeking AlphaMar 8 10:00 ET

Samsara, DocuSign, Gap Among Premarket Gainers' Pack

Seeking AlphaMar 8 08:30 ET

Top Premarket Gainers

Ainos (AIMD) shares surged more than 149%, reversing Thursday's slide. CERo Therapeutics (CERO) shares rose 55%, extending Thursday's rally. Gulf Island Fabrication (GIFI) shares advanced 27% after th

MT NewswiresMar 8 07:48 ET

CERo Therapeutics (CERO) Sees Massive Volume & Price Surge on Preclinical Success

CERo Therapeutics Holdings, Inc. (NASDAQ: CERO) saw a meteoric rise yesterday, surging by a jaw-dropping 20.8%. However, the real fireworks ignited during the early premarket hours on Friday, as CERO catapulted by an astounding 54%, bringing its price close to $4.73. This astronomical surge was fueled by robust preclinical results, hinting at the promise of ...

Stocks TelegraphMar 8 05:49 ET

Trending Stocks Today: Ainos Surges 195.53% Pre-Market

March 8th - US stocks trending pre-market: Gainers: $Ainos(AIMD.US)$ surges 195.53% to $3.31 with a turnover of $11.93 million. $MIRA Pharmaceuticals(MIRA.US)$ soars 67.38% to $1.59 with a turnover of

moomoo NewsMar 8 05:20 ET

Viking Therapeutics, Creative Medical Technology, Aptorum Group Among Healthcare Movers

Seeking AlphaMar 7 11:37 ET

Why CERo Therapeutics Stock Is Soaring

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares are racing higher Thursday after the company announced the publication of preclinical research on the use of its clinical candidate CER-1236 to tr

BenzingaMar 7 11:28 ET

Express News | CERo Therapeutics Shares Are Trading Higher After the Company Announced the Publication of Preclinical Research Analyzing CER-1236 in Targeting Acute Myelogenous Leukemia Tumor Cells From Human Patients

Moomoo 24/7Mar 7 10:40 ET

Express News | CERo Therapeutics Shares Halted On Circuit Breaker

Moomoo 24/7Mar 7 09:47 ET